Literature DB >> 21519633

Bone marrow stromal cell-derived vascular endothelial growth factor (VEGF) rather than chronic lymphocytic leukemia (CLL) cell-derived VEGF is essential for the apoptotic resistance of cultured CLL cells.

Iris Gehrke1, Rajesh Kumar Gandhirajan, Simon Jonas Poll-Wolbeck, Michael Hallek, Karl-Anton Kreuzer.   

Abstract

Chronic lymphocytic leukemia (CLL) cells feature a pronounced apoptotic resistance. The vascular endothelial growth factor (VEGF) possesses a role in this apoptotic block, although underlying functional mechanisms and the involvement of the microenvironment are unclear. In this study, the VEGF status in CLL was assessed by enzyme-linked immunosorbent assay and immunofluorescence. VEGF receptor 2 (VEGFR2) phosphorylation was determined flow cytometrically and by immunofluorescence. For co-culture, CLL cells were cultivated on a monolayer of the bone marrow-derived stromal cell (BMSC) line HS5. Secreted VEGF was neutralized using the monoclonal antibody mAb293 (R&D Systems, Minneapolis, MN, USA). To block protein secretion, we used Brefeldin A. VEGF was downregulated in BMSCs by small interfering RNA (siRNA), and we assessed survival by annexin V-fluorescein isothiocyanate (FITC)/propidium iodide (PI) staining. CLL cells express and secrete VEGF and possess phosphorylated VEGFR2. This positive VEGF status is not sufficient to prevent spontaneous apoptosis in vitro. Coculture with BMSCs, which secrete vast amounts of VEGF, maintains in vitro CLL cell survival. Blockage of secreted VEGF using the monoclonal antibody mAb293 significantly reduced the survival support for cocultured CLL cells. Both general blockage of protein secretion by Brefeldin A in BMSCs, but not in CLL cells, and siRNA-mediated downregulation of VEGF in BMSCs, significantly reduced the coculture-mediated survival support for CLL cells. It can be concluded that BMSC-derived proteins and VEGF, in particular, but not CLL cell-derived VEGF, is essentially involved in the coculture-mediated survival support for CLL cells. Hence, therapeutic targeting of VEGF signaling might be a promising approach to overcome the apoptotic resistance CLL cells feature within their natural microenvironment.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21519633      PMCID: PMC3146618          DOI: 10.2119/molmed.2010.00210

Source DB:  PubMed          Journal:  Mol Med        ISSN: 1076-1551            Impact factor:   6.354


  32 in total

1.  VEGF-induced survival of chronic lymphocytic leukemia is independent of Bcl-2 phosphorylation.

Authors:  L Wang; J E Coad; J M Fortney; L F Gibson
Journal:  Leukemia       Date:  2005-08       Impact factor: 11.528

2.  Bone biopsy derived marrow stromal elements rescue chronic lymphocytic leukemia B-cells from spontaneous and drug induced cell death and facilitates an "angiogenic switch".

Authors:  Neil E Kay; Tait D Shanafelt; Ann K Strege; Yean K Lee; Nancy D Bone; Azra Raza
Journal:  Leuk Res       Date:  2007-01-22       Impact factor: 3.156

3.  Efficient nucleofection of primary human B cells and B-CLL cells induces apoptosis, which depends on the microenvironment and on the structure of transfected nucleic acids.

Authors:  M Seiffert; S Stilgenbauer; H Döhner; P Lichter
Journal:  Leukemia       Date:  2007-07-19       Impact factor: 11.528

4.  The vascular endothelial growth factor receptor tyrosine kinase inhibitors vatalanib and pazopanib potently induce apoptosis in chronic lymphocytic leukemia cells in vitro and in vivo.

Authors:  Julian Paesler; Iris Gehrke; Rajesh Kumar Gandhirajan; Alexandra Filipovich; Magdalena Hertweck; Felix Erdfelder; Sabrina Uhrmacher; Simon Jonas Poll-Wolbeck; Michael Hallek; Karl-Anton Kreuzer
Journal:  Clin Cancer Res       Date:  2010-06-22       Impact factor: 12.531

5.  Circulating vascular endothelial growth factor (VEGF) and its soluble receptors in patients with chronic lymphocytic leukemia.

Authors:  Joanna Gora-Tybor; Jerzy Z Blonski; Tadeusz Robak
Journal:  Eur Cytokine Netw       Date:  2005 Jan-Mar       Impact factor: 2.737

6.  Chronic lymphocytic leukemic B cells but not normal B cells are rescued from apoptosis by contact with normal bone marrow stromal cells.

Authors:  L Lagneaux; A Delforge; D Bron; C De Bruyn; P Stryckmans
Journal:  Blood       Date:  1998-04-01       Impact factor: 22.113

7.  Autocrine VEGF mediates the antiapoptotic effect of CD154 on CLL cells.

Authors:  M Farahani; A T Treweeke; C H Toh; K J Till; R J Harris; J C Cawley; M Zuzel; H Chen
Journal:  Leukemia       Date:  2005-04       Impact factor: 11.528

8.  VEGF receptors on chronic lymphocytic leukemia (CLL) B cells interact with STAT 1 and 3: implication for apoptosis resistance.

Authors:  Y K Lee; T D Shanafelt; N D Bone; A K Strege; D F Jelinek; N E Kay
Journal:  Leukemia       Date:  2005-04       Impact factor: 11.528

Review 9.  Molecular pathogenesis of chronic lymphocytic leukemia: factors and signaling pathways regulating cell growth and survival.

Authors:  G Meinhardt; C M Wendtner; M Hallek
Journal:  J Mol Med (Berl)       Date:  1999-02       Impact factor: 4.599

10.  Circulating microvesicles in B-cell chronic lymphocytic leukemia can stimulate marrow stromal cells: implications for disease progression.

Authors:  Asish K Ghosh; Charla R Secreto; Traci R Knox; Wei Ding; Debabrata Mukhopadhyay; Neil E Kay
Journal:  Blood       Date:  2009-12-17       Impact factor: 22.113

View more
  14 in total

1.  Angiogenesis in Liquid Tumors: An In Vitro Assay for Leukemic-Cell-Induced Bone Marrow Angiogenesis.

Authors:  Yi Zheng; Yubing Sun; Xinwei Yu; Yue Shao; Ping Zhang; Guohao Dai; Jianping Fu
Journal:  Adv Healthc Mater       Date:  2016-02-29       Impact factor: 9.933

2.  The Therapeutic Effects of Human Mesenchymal Stem Cells Primed with Sphingosine-1 Phosphate on Pulmonary Artery Hypertension.

Authors:  Hyunsook Kang; Kang-Hyun Kim; Jisun Lim; You-Sun Kim; Jinbeom Heo; Jongjin Choi; Jaeho Jeong; YongHwan Kim; Seong Who Kim; Yeon-Mok Oh; Myung-Soo Choo; Jaekyoung Son; Su Jung Kim; Hyun Ju Yoo; Wonil Oh; Soo Jin Choi; Sei Won Lee; Dong-Myung Shin
Journal:  Stem Cells Dev       Date:  2015-04-09       Impact factor: 3.272

3.  Vascular endothelial growth factor levels in childhood acute lymphoblastic and myeloblastic leukemia.

Authors:  Göksel Leblebisatan; Bülent Antmen; Ilgen Saşmaz; Yurdanur Kilinç
Journal:  Indian J Hematol Blood Transfus       Date:  2011-08-17       Impact factor: 0.900

Review 4.  Targeting chronic lymphocytic leukemia cells in the tumor microenviroment: A review of the in vitro and clinical trials to date.

Authors:  Kyle Crassini; Stephen P Mulligan; O Giles Best
Journal:  World J Clin Cases       Date:  2015-08-16       Impact factor: 1.337

Review 5.  Biology of chronic lymphocytic leukemia in different microenvironments: clinical and therapeutic implications.

Authors:  Yair Herishanu; Ben-Zion Katz; Andrew Lipsky; Adrian Wiestner
Journal:  Hematol Oncol Clin North Am       Date:  2013-04       Impact factor: 3.722

6.  DNA damage response and evasion from immunosurveillance in CLL: new options for NK cell-based immunotherapies.

Authors:  Olga M Shatnyeva; Hinrich P Hansen; Katrin S Reiners; Maike Sauer; Maulik Vyas; Elke Pogge von Strandmann
Journal:  Front Genet       Date:  2015-02-04       Impact factor: 4.599

7.  Effect of bone marrow mesenchymal stem cells on experimental pulmonary arterial hypertension.

Authors:  Zhao-Hua Zhang; Yan Lu; Yun Luan; Jing-Jie Zhao
Journal:  Exp Ther Med       Date:  2012-08-31       Impact factor: 2.447

8.  VEGF and bFGF gene polymorphisms in Polish patients with B-CLL.

Authors:  Tomasz Wróbel; Grzegorz Mazur; Justyna Dzietczenia; Katarzyna Gebura; Kazimierz Kuliczkowski; Katarzyna Bogunia-Kubik
Journal:  Med Oncol       Date:  2013-01-19       Impact factor: 3.064

9.  Vascular endothelial growth factor A (VEGFA) gene polymorphisms have an impact on survival in a subgroup of indolent patients with chronic lymphocytic leukemia.

Authors:  Carol Lozano-Santos; Jimena Martinez-Velasquez; Belen Fernandez-Cuevas; Natividad Polo; Belen Navarro; Isabel Millan; Jose Miguel Garcia; Rosa Collado; Pedro Sanchez-Godoy; Felix Carbonell; Jose Antonio Garcia-Vela; Jose Antonio Garcia-Marco; Natalia Gomez-Lozano
Journal:  PLoS One       Date:  2014-06-27       Impact factor: 3.240

10.  Efficient lysis of B-chronic lymphocytic leukemia cells by the plant-derived sesquiterpene alcohol α-bisabolol, a dual proapoptotic and antiautophagic agent.

Authors:  Antonella Rigo; Isacco Ferrarini; Angela Bonalumi; Cristina Tecchio; Alessio Montresor; Carlo Laudanna; Fabrizio Vinante
Journal:  Oncotarget       Date:  2018-05-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.